Триггерная роль COVID-19 в развитии сахарного диабета 1-го типа и кетоацидоза у ребенка: случай из практики
https://doi.org/10.22627/2072-8107-2023-22-2-56-60
Abstract
It has been proven that the SARS-CoV-2 virus is able to initiate the development of a number of metabolic disorders, leading to diabetes mellitus (DM). Given the high frequency of cases of newly diagnosed type 1 diabetes in children, as well as possible adverse prospective consequences, the study of such clinical cases seems to us to be an extremely relevant practice for doctors of all specialties. The aim of the study was to to demonstrate of a clinical case of newly diagnosed type 1 diabetes in a child with COVID-19.
The article presents a general understanding of the pathogenetically bidirectional relationship between a new coronavirus infection and diabetes mellitus, presents a clinical case of type 1 diabetes diagnosed for the first time in a child 3 years 8 months with COVID-19, and describes the further stage of treatment in the specialized endocrinology department.
Conclusion. The clinical case presented by us, as well as data obtained as a result of research by domestic and foreign colleagues, confirm the existence of a pathogenetically determined relationship between COVID-19 and type 1 diabetes mellitus in children. To better understand the mechanisms underlying the devel- opment of metabolic suffering, it is necessary to create a single Global registry of patients with diabetes mellitus, first identified in connection with COVID-19.
About the Authors
V. V. Sokolovskaya
Smolensk State Medical University
Russian Federation
Russian Federation
Smolensk
A. A. Litvinova
Smolensk State Medical University
Russian Federation
Russian Federation
Smolensk
N. N. Smolyankin
Smolensk State Medical University
Russian Federation
Russian Federation
Smolensk
A. V. Krikova
Smolensk State Medical University
Russian Federation
Russian Federation
Smolensk
R. S. Kozlov
Smolensk State Medical University
Russian Federation
Russian Federation
Smolensk
References
1. Erener S. Diabetes, infection risk and COVID-19. Mol Metab. 2020 Sep; 39:101044. doi: 10.1016/j.molmet.2020.101044.
2. [Dedov I.I., Mokrysheva N.G., Shestakova M.V., Nikonova T.V. et al. Glycemic control and choice of antihyperglycemic therapy in patients with type 2 diabetes mellitus and COVID-19: consensus decision of the Council of Experts of the Russian Association of Endocrinologists. Diabetes Мellitus. 2022; 25(1):27—49. (In Russ.)]
3. Wu Z.H., Tang Y., Cheng Q. Diabetes increases the mortality of patients with COVID-19: a meta-analysis. Acta Diabetol. 2021 Feb; 58(2):139—144. doi: 10.1007/s00592-020-01546-0.
4. Gottesman B.L., Yu J., Tanaka C., Longhurst C.A., Kim J.J. Incidence of New-Onset Type 1 Diabetes Among US Children During the COVID-19 Global Pandemic. JAMA Pediatr. 2022 Apr 1; 176(4):414—415. doi: 10.1001/jamapediatrics.2021.5801.
5. Rahmati M., Keshvari M., Mirnasuri S., Yon D.K., Lee S.W., Il Shin J., Smith L. The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis. J Med Virol. 2022 Nov; 94(11):5112—5127. doi: 10.1002/jmv.27996.
6. Gagnum V., Stene LC, Jenssen TG, Berteussen LM, Sandvik L, Joner G, Njølstad PR, Skrivarhaug T. Causes of death in childhood-onset Type 1 diabetes: long-term follow-up. Diabet Med. 2017 Jan; 34(1):56—63. doi: 10.1111/dme.13114.
7. Wasag D.R., Gregory JW, Dayan C, Harvey JN; Brecon Group. Excess all-cause mortality before age 30 in childhood onset type 1 diabetes: data from the Brecon Group Cohort in Wales. Arch Dis Child. 2018 Jan; 103(1):44—48. doi: 10.1136/archdischild-2016-312581.
8. Scheen A.J., Marre M, Thivolet C. Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports. Diabetes Metab. 2020 Sep; 46(4):265—271. doi: 10.1016/j.diabet.2020.05.008.
9. Sathish T, Tapp RJ, Cooper ME, Zimmet P. Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. Diabetes Metab. 2021 Mar; 47(2):101204. doi: 10.1016/j.diabet.2020.10.002.
10. Zhang T Mei Q, Zhang Z, Walline JH, Liu Y, Zhu H, Zhang S. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med. 2022 Nov 15; 20(1):444. doi: 10.1186/s12916-022-02656-y.
11. [Khaydarova F.A., Alimova N.U., Alieva A.V., Sadykova A.S., Aripova M.D. Impact of COVID-19 infection on the development of type 1 diabetes mellitus in children and adolescents. Diabetes Mellitus. 2022; 25(1):21—26. (In Russ.)]
Review
For citations:
Sokolovskaya V.V., Litvinova A.A., Smolyankin N.N., Krikova A.V., Kozlov R.S. Триггерная роль COVID-19 в развитии сахарного диабета 1-го типа и кетоацидоза у ребенка: случай из практики. CHILDREN INFECTIONS. 2023;22(2):56-60. (In Russ.) https://doi.org/10.22627/2072-8107-2023-22-2-56-60
Views:
377
Email this article 